Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heinonen

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Selegiline as primary treatment in early phase Parkinson's disease--an interim reportV V Myllylä, K A Sotaniemi, J Tuominen, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's diseaseE H Heinonen, M Savijärvi, M Kotila, et al.
Environmental Technology|June 15, 2010
Nitrogen reduction in wastewater treatment using different anox-circulation flow rates and ethanol as a carbon sourceH Poutiainen, S Laitinen, S Pradhan, et al.
Letters in Applied Microbiology|March 6, 2012
Airborne enteric micro-organisms and ammonia levels in diaper-changing rooms in kindergartensP E Vaattovaara, M Kivimäenpää, P Vaattovaara, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|July 24, 2001
Determination of salmonellae from municipal wastewatersJ Koivunen, E Lanki, R L Rajala, et al.
Neurology|February 1, 1992
Selegiline as initial treatment in de novo parkinsonian patientsV V Myllylä, K A Sotaniemi, J A Vuorinen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
Selegiline in de novo parkinsonian patients: the Finnish studyV V Myllylä, K A Sotaniemi, J A Vuorinen, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Optoelectronic movement analysis in Parkinson's disease: effect of selegiline on the disability in de novo parkinsonian patients--a pilot studyB Johnels, P E Ingvarsson, M Matousek, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Selegiline as a primary treatment of Parkinson's diseaseV V Myllylä, K A Sotaniemi, J A Vuorinen, et al.
Annals of Hematology|April 26, 2001
Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantationH Heinonen, L Volin, A Uutela, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Selegiline as primary treatment in early phase Parkinson's disease--an interim reportV V Myllylä, K A Sotaniemi, J Tuominen, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's diseaseE H Heinonen, M Savijärvi, M Kotila, et al.
Environmental Technology|June 15, 2010
Nitrogen reduction in wastewater treatment using different anox-circulation flow rates and ethanol as a carbon sourceH Poutiainen, S Laitinen, S Pradhan, et al.
Letters in Applied Microbiology|March 6, 2012
Airborne enteric micro-organisms and ammonia levels in diaper-changing rooms in kindergartensP E Vaattovaara, M Kivimäenpää, P Vaattovaara, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|July 24, 2001
Determination of salmonellae from municipal wastewatersJ Koivunen, E Lanki, R L Rajala, et al.
Neurology|February 1, 1992
Selegiline as initial treatment in de novo parkinsonian patientsV V Myllylä, K A Sotaniemi, J A Vuorinen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
Selegiline in de novo parkinsonian patients: the Finnish studyV V Myllylä, K A Sotaniemi, J A Vuorinen, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Optoelectronic movement analysis in Parkinson's disease: effect of selegiline on the disability in de novo parkinsonian patients--a pilot studyB Johnels, P E Ingvarsson, M Matousek, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Selegiline as a primary treatment of Parkinson's diseaseV V Myllylä, K A Sotaniemi, J A Vuorinen, et al.
Annals of Hematology|April 26, 2001
Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantationH Heinonen, L Volin, A Uutela, et al.
Pageof 6